Latest Regulatory News

Korvest Ltd has announced a fully franked ordinary dividend of AUD 0.25 per share for the six months ending December 2024, signaling steady shareholder returns.

Nimy Resources has addressed an ASX inquiry regarding recent spikes in its share price and trading volume, confirming no undisclosed information but highlighting ongoing work on its maiden JORC Exploration Target for gallium.

Centrex Limited has updated the timetable for its $10.4 million Entitlement Offer, with the offer opening on 28 January and closing on 19 February 2025. The company aims to bolster its position in sustainable agriculture through this capital raise.

Agrimin Limited has achieved a major regulatory milestone with Western Australia's environmental approval for its Mackay Potash Project, advancing its path toward sustainable fertiliser production.

Bounty Oil & Gas NL has been notified of the refusal of its Joint Venture Applications for the PEP 11 permit, which remains valid for two months. The company is now considering a legal challenge to this decision.

Xanadu Mines has lodged a comprehensive NI 43-101 technical report for its Kharmagtai Copper-Gold Project, revealing key differences in production and economic outcomes compared to earlier ASX disclosures due to regulatory standards.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

Wellard Limited has disclosed the binding sale of its last livestock vessel, the M/V Ocean Drover, for US$50 million, with plans to return the net proceeds to shareholders pending approval.

Immuron Limited reports a striking 70% quarter-on-quarter increase in Travelan® sales, driven by expanded pharmacy distribution in Australia and North America.

Beam Dental Bidco Pty Ltd has extended its off-market takeover offer for Pacific Smiles Group Limited, pushing the closing date to January 30, 2025. This extension signals ongoing negotiations and a potentially protracted acquisition process.

Artrya Limited has responded to an ASX price query following a notable surge in its share price, confirming no undisclosed information and adherence to continuous disclosure rules.

Visioneering Technologies reports promising interim results from its PROTECT trial, showing significant control of myopia progression in children using NaturalVue® Multifocal lenses.